ReviewUpdates in surgery2026
Reflections on surgery for hiatal hernia.
Review in Updates in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Efficacy and safety of mesh reinforced cruroplasty with Phasix™ ST vs. Bio-AHernia : the journal of hernias and abdominal wall surgery · 2026Pooled it
- Towards a neuro-symbolic approach for precision anti-reflux surgery.Updates in surgery · 2026Review
- Artificial intelligence for surgical management of benign esophageal disease: scoping review and evidence mapping.Langenbeck's archives of surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gastroesophageal reflux disease and hiatal hernia are highly prevalent, chronic, and heterogeneous disfunctions with a profound impact on patient's quality of life. Impairment of the antireflux barrier -which includes the lower esophageal sphincter, the gastroesophageal flap valve, and the crural diaphragm- is the main pathophysiological factor responsible for symptoms and complications. Accurate diagnosis mandates a comprehensive multidisciplinary assessment including upper endoscopy, high-resolution manometry, barium esophagram, and ambulatory pH or pH-impedance monitoring to characterize anatomical defects, motility abnormalities, and reflux severity. Well selected individuals with refractory or complicated reflux disease, and those with large hiatal hernia and intrathoracic stomach, may benefit from laparoscopic surgical management including crural repair and fundoplication to restore the antireflux barrier. Nissen fundoplication is highly effective in controlling reflux but it may be associated with postoperative dysphagia and gas-bloat syndrome. Partial fundoplication can offer comparable reflux control with reduced adverse effects, especially in patients with impaired esophageal motility. Novel devices such as the LINX and the RefluxStop show promise in augmenting the lower esophageal sphincter with favorable safety profiles. The role of mesh reinforcement for hiatal repair remains contentious due to unpredictable outcomes and risk of complications. Robotic-assisted surgery offers enhanced technical precision but has yet to demonstrate significant clinical superiority and incurs greater costs compared to laparoscopy. Artificial intelligence applications are emerging as valuable adjuncts for preoperative planning, intraoperative guidance, and postoperative monitoring, potentially improving procedural standardization and surgical outcomes.
Indexed as
Identifiers
41430014What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.